about
Therapeutic plasmapheresis for the treatment of the thrombotic thrombocytopenic purpura-haemolytic uraemic syndromes.Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome.Use of phage display to isolate specific human monoclonal antibody fragments against a potential target for multiple myeloma.Low-dose insulin-like growth factor binding proteins 1 and 2 and angiopoietin-like protein 3 coordinately stimulate ex vivo expansion of human umbilical cord blood hematopoietic stem cells as assayed in NOD/SCID gamma null mice.Clinical activity of the new triazole drug voriconazole (UK 109, 496) against disseminated hepatosplenic aspergillosis in a patient with relapsed leukemia.Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation.Haematopoietic graft engineering.Allogeneic haematopoietic stem cell transplantation without a matched sibling donor: current options and future potential.Treatment of blastic plasmacytoid dendritic cell neoplasms with cord blood transplants.Expansion and homing of umbilical cord blood hematopoietic stem and progenitor cells for clinical transplantation.A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication.Mitochondrial superoxide reduction and cytokine secretion skewing by carbon nanotube scaffolds enhance ex vivo expansion of human cord blood hematopoietic progenitors.Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation.Cost and quality issues in establishing hematopoietic cell transplant program in developing countries.Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation.Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association.Novel HLA class I and II alleles identified during routine registry typing in 2010.Study of gene expression profile during cord blood-associated megakaryopoiesis.Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.BK-virus prophylaxis: still no answer.Thirty Years of Bone Marrow Transplantation in the Singapore General Hospital.Characterization of new HLA-B and -DRB1 alleles from Singapore.Ex Vivo Expansion of CD34+ CD90+ CD49f+ Hematopoietic Stem and Progenitor Cells from Non-enriched Umbilical Cord Blood with Azole Compounds.Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy.Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population.Concurrent intermediate uveitis and an enhancing intracranial lesion as the initial manifestation of sarcoidosis.Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group.Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned.Developmental Analysis of Bone Marrow Neutrophils Reveals Populations Specialized in Expansion, Trafficking, and Effector Functions.Use of human germline genes in a CDR homology-based approach to antibody humanization.Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.HLA haplotypes in Singapore: a study of mothers and their cord blood units.Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation.Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantation.Detection and quantification of the abelson tyrosine kinase domains of the BCR-ABL gene translocation in chronic myeloid leukaemia using genomic quantitative real-time polymerase chain reaction.Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.
P50
Q33360792-77058B98-BC34-4790-93AE-3B2A2C1F6AD8Q33383210-DC636A5C-230C-4725-AE57-FB65A12BED5AQ33490148-FD196527-CDF1-4C18-8471-31A4955F8D8DQ33827042-025DAEAB-FA6E-4C7E-ACD3-F6B6FA31ACA9Q34246887-68C0EC11-0C28-4FFC-9124-7EAC8550C13AQ34557754-34E60F2D-36A1-4C77-9A8C-4902AE549A87Q35668187-41962506-B7B6-4109-AAEF-11B83739B1DBQ35942529-8C46148F-8207-4ECE-88D7-78F5099BB190Q37478168-670AEEF3-6ADA-4D8C-9F63-2D10966F3CD6Q37991921-5BCCC7B2-341B-4970-9ED5-D4688A56CEE5Q38306093-0652A323-B1B5-47F9-AD9B-ED78A286F44CQ38323097-9533A1C3-32D6-45FA-B848-7DCC7DE31F23Q38802147-D20EF23A-14DE-4371-9902-4A5E44D383A6Q38991047-D09BC439-8C90-40BF-BD8E-3F7129511D1CQ39018396-5741B4C4-64F2-42D0-9FC1-2ADFF7D35ABAQ39450725-67B11E13-92A9-42AE-9C69-C71C0EA02F99Q39574491-63F73D09-36B5-4EC8-9592-6B6CA7BA2B10Q40531384-F8E62A56-8988-498E-9258-72278E317C55Q40610770-4ED92177-C81F-4D86-8440-6E6B2716038FQ42783305-62CA0418-284D-423B-99DD-3066D0C1D55FQ42817074-81170BDE-1262-4D3C-BBBD-541374BC40CBQ43472472-5C7E1E03-43D6-4532-8F65-3E16606B5084Q43518495-9145FE4B-81E3-4D9F-8B26-73AEF94C71F4Q45351373-470C12BF-EC39-45C2-B2DE-B25C15534184Q47675911-F2D93642-D18A-4422-9AEA-FF908DE70BE7Q48071559-F50AC72A-3382-47D4-B6CC-0E41F47B1E00Q48116992-9925E665-F2A6-4E75-AC5A-785A88E4E6A1Q48200984-3F810848-6006-4154-9DBD-0F539646435DQ48297473-2357B9C4-175D-4174-83ED-59B97B175D4AQ48532711-E7CDDE0B-A6CF-4F45-8F79-9BF9F8A24936Q48848774-5A0D89C7-C684-4C60-B2BC-87C8D4AB0485Q50248907-6111F4F1-E7E3-472E-8C35-46557DB56471Q50422442-CC871586-F32C-42BE-AA23-08995800749EQ51494284-4EAEF60A-D63D-4057-8962-A01020FE699BQ51824124-F64D8380-1E47-4D35-A619-22FEC13B13D9Q51916284-A62BF0F2-C89B-456F-B537-1FD7BCC3A0A1Q53106181-CFB3D4E3-54E9-426B-AAC5-95C314F5B179Q54051617-A2C7CCFB-FCBD-4A2B-ABC6-810F85FF24D4Q54571617-0899B48E-C0DD-4F83-8E4D-D768AD6C4B95Q64976532-2031C4F0-005A-461F-A775-C4265E3DFD30
P50
description
researcher
@en
wetenschapper
@nl
name
Hwang J
@nl
William Ying Khee Hwang
@en
type
label
Hwang J
@nl
William Ying Khee Hwang
@en
prefLabel
Hwang J
@nl
William Ying Khee Hwang
@en
P108
P106
P31
P496
0000-0003-0143-6263